A purple and pink letter v on a white background.
July 11, 2019

Introducing Venus Bliss™: A Comprehensive Solution to Target Fat

Is your aesthetics business equipped to get a share of the one treatment category that’s estimated to be worth $2.5 billion globally by the year 2025? We’re talking about fat reduction, which also happened to be the fastest growing non-surgical treatment category last year, according to the American Society for Aesthetic Plastic Surgery(ASAPS). With our newest device, Venus Bliss™, you’ll be able to reap the benefits of this substantial growth.

Venus Bliss™, the newest addition to our suite of devices, is now available in the U.S. for non-invasive lipolysis of the abdomen and flanks, resulting in fat reduction. With Venus Bliss™, you can offer a safe and comfortable solution to target fat without worrying about any “cycle” or usage fees per treatment. Fat reduction is also one of the rare treatment categories where growth in the male market has been stronger than in the female market, enabling you to reach a wider demographic.

In addition to lipolysis treatments, Venus Bliss™ also comes with an (MP) 2 applicator that can be used to reduce cellulite around the abdomen, as well as on the buttocks and thighs, for a smoother, more contoured appearance.

What Does Venus Bliss™ Do?

Venus Bliss™ features four diode laser applicators, which deliver laser energy that effectively penetrates into the hypodermis to target adipose tissue without harming the skin’s surface. The disrupted fat cells are then eliminated through the body’s natural lymphatic system, resulting in fat reduction. Each diode laser applicator is equipped to achieve lipolysis as effectively, safely, and comfortably as possible for the patient.

The (MP) 2 applicator is powered by our patented combination of Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields, along with advanced VariPulse™ technology. The combination of these technologies reduces the appearance of abdominal cellulite, resulting in smoother skin and the enhanced appearance of the treatment area. The (MP) 2 applicator can also be used to target cellulite around the thighs and buttocks.

Both diode laser treatments with Venus Bliss™ and radio frequency technology are safe for all skin types.

Clinically Validated Efficacy

In one 30-patient study where all patients received a diode laser treatment to either their flanks or abdomen, the majority of patients were found to have a statistically significant reduction in adipose layer thickness when measured by ultrasound. When surveyed, 75% of patients were satisfied with their results and would recommend the treatment to a friend. Over 90% of the patients also reported that the treatment was comfortable.

To learn more about how Venus Bliss™ can help you take your aesthetics business to the next level, contact one of our experts today using the button below.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.